Patients, n, % (95% CI) | Hazard ratio* (95% CI) | P value | ||
---|---|---|---|---|
Angiotensin II > 5 ng kg−1 min−1 | Angiotensin II ≤ 5 ng kg−1 min−1 | |||
Baseline MAP | ||||
≥ 65 mmHg | 47, 44.7 (30.2–58.1) | 64, 67.2 (54.2–77.2) | 0.52 (0.29–0.92) | 0.023 |
< 65 mmHg | 37, 37.4 (22.1–52.7) | 15, 66.7 (37.5–84.6) | 0.38 (0.14–1.00) | 0.041 |
Baseline norepinephrine-equivalent dose | ||||
< 0.5 µg kg−1 min−1 | 50, 47.4 (33.0–60.5) | 67, 68.7 (56.1–78.3) | 0.53 (0.30–0.95) | 0.030 |
≥ 0.5 µg kg−1 min−1 | 34, 32.4 (17.6–48.0) | 12, 58.3 (27.0–80.1) | 0.45 (0.17–1.19) | 0.100 |
Baseline angiotensin I | ||||
< 72.3 pg/mL | 12, 41.7 (15.2–66.5) | 24, 66.7 (44.3–81.7) | 0.49 (0.18–1.35) | 0.160 |
72.3 to < 253 pg/mL | 14, 42.9 (17.7–66.0) | 19, 57.9 (33.2–76.3) | 0.56 (0.21–1.48) | 0.234 |
253 to < 676 pg/mL | 25, 39.3 (20.5–57.6) | 14, 85.7 (53.9–96.2) | 0.18 (0.04–0.80) | 0.011 |
≥ 676 pg/mL | 23, 52.2 (30.5–70.0) | 14, 50.0 (22.9–72.2) | 1.02 (0.40–2.64) | 0.962 |
Baseline angiotensin II | ||||
< 23.85 pg/mL | 14, 28.6 (8.8–52.4) | 21, 71.4 (47.2–86.0) | 0.29 (0.10–0.80) | 0.011 |
23.85 to < 83.75 pg/mL | 11, 36.4 (11.2–62.7) | 21, 71.4 (47.2–86.0) | 0.37 (0.12–1.09) | 0.060 |
83.75 to < 299.5 pg/mL | 25, 43.2 (23.5–61.5) | 21, 57.1 (33.8–74.9) | 0.64 (0.27–1.47) | 0.285 |
≥ 299.5 pg/mL | 24, 58.3 (36.4–75.0) | 7, 57.1 (17.2–83.7) | 1.01 (0.28–3.66) | 0.993 |